Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000028880Phase 4Not yet recruiting
Phase 4, randomised, double-blind trial of butorphanol in Nasal condition (2 arms), sponsored by The First Affiliated Hospital of Shantou University Medical College. Primary endpoint: pain. Planned start Jan 2020; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000028880.